Working… Menu

Efficacy and Safety Study of Ingavirin® to Treat Influenza and Other Acute Respiratory Viral Infections in Patients 3-6 y.o. (ACCORD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02644018
Recruitment Status : Completed
First Posted : December 31, 2015
Last Update Posted : June 9, 2016
Atlant Clinical Ltd.
Information provided by (Responsible Party):
Valenta Pharm JSC

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 2016
Actual Study Completion Date : May 2016